Catechol-O-methyltransferase inhibitors in Parkinson's disease

被引:2
作者
Xie, T
Ho, SL [1 ]
Ramsden, D
机构
[1] Univ Birmingham, Queen Elizabeth Hosp, Dept Med, Birmingham B15 2TH, W Midlands, England
[2] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Peoples R China
关键词
D O I
10.1016/S0140-6736(05)78660-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1966 / 1966
页数:1
相关论文
共 4 条
[1]  
BELL KM, 1988, AM J PSYCHIAT, V145, P1110
[2]   CEREBROSPINAL-FLUID S-ADENOSYLMETHIONINE IN DEPRESSION AND DEMENTIA - EFFECTS OF TREATMENT WITH PARENTERAL AND ORAL S-ADENOSYLMETHIONINE [J].
BOTTIGLIERI, T ;
GODFREY, P ;
FLYNN, T ;
CARNEY, MWP ;
TOONE, BK ;
REYNOLDS, EH .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1990, 53 (12) :1096-1098
[3]  
Cooper J, 1982, BIOCH BASIS NEUROPHA
[4]   Catechol-O-methyltransferase inhibitors for treatment of Parkinson's disease [J].
Nutt, JG .
LANCET, 1998, 351 (9111) :1221-1222